{
  "image_filename": "figure_p5_det_4_002.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p5_det_4_002.png",
  "image_type": "Figure",
  "page_number": 5,
  "block_id": "det_4_002",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "Two Kaplan\u2013Meier plots showing cumulative incidence of culture-positive CDC-defined influenza-like illness for influenza A (top) and influenza B (bottom) during the surveillance period in placebo (solid line) and FluBlok (dotted line) recipients, with associated vaccine efficacy data in text below. The figure presents incidence curves and efficacy percentages; it does not provide any information on antigenic matching to WHO- or FDA-selected strains and therefore does not support the claim.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Two Kaplan\u2013Meier plots showing cumulative incidence of culture-positive CDC-defined influenza-like illness for influenza A (top) and influenza B (bottom) during the surveillance period in placebo (solid line) and FluBlok (dotted line) recipients, with associated vaccine efficacy data in text below.",
    "evidence_found": null,
    "reasoning": "The figure presents incidence curves and efficacy percentages; it does not provide any information on antigenic matching to WHO- or FDA-selected strains and therefore does not support the claim.",
    "confidence_notes": null
  }
}